Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer L Lund

Showing results (1-10 of 232) with videos related to

Pageof 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2013
Common flaws in pharmacoepidemiologic study design and analysisJennifer L Lund, Jonathan Montomoli
Cancer|May 3, 2022
Noncancer comparators in cancer survivorship studiesJessica Chubak, Jennifer L Lund
American Journal of Epidemiology|June 19, 2024
Identifying target populations to align with decision-makers' needsJennifer L Lund, Anthony A Matthews
Pharmacoepidemiology and Drug Safety|June 1, 2023
Pharmacoepidemiology and Drug Safety's core concepts in pharmacoepidemiology section at 1 year: Where do we go from here?Jennifer L Lund, Vincent Lo Re
Current Epidemiology Reports|January 23, 2019
The importance and implications of comparator selection in pharmacoepidemiologic researchMonica D'Arcy, Til Stürmer, Jennifer L Lund
JAMA Internal Medicine|April 4, 2018
Lower Cancer Incidence-Warfarin Effect or Immortal Time Bias?Xiaojuan Li, Jennifer L Lund, Sengwee Toh
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2025
Investigating Racial and Ethnic Disparities Along the Care Cascade for Older Adults Newly Diagnosed With Metastatic CancerJennifer L Lund, Vanessa E Slater, Allison Magnuson
JAMA|September 20, 2012
Benefits and risks of aspirin useJennifer L Lund, Til Stürmer, Henrik Toft-Sørensen
Current Epidemiology Reports|March 9, 2016
The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary applicationJennifer L Lund, David B Richardson, Til Stürmer
Journal of Geriatric Oncology|March 2, 2016
Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapyJennifer L Lund, Til Sturmer, Hanna K Sanoff
Pageof 24

Showing results (1-10 of 232) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2013
Common flaws in pharmacoepidemiologic study design and analysisJennifer L Lund, Jonathan Montomoli
Cancer|May 3, 2022
Noncancer comparators in cancer survivorship studiesJessica Chubak, Jennifer L Lund
American Journal of Epidemiology|June 19, 2024
Identifying target populations to align with decision-makers' needsJennifer L Lund, Anthony A Matthews
Pharmacoepidemiology and Drug Safety|June 1, 2023
Pharmacoepidemiology and Drug Safety's core concepts in pharmacoepidemiology section at 1 year: Where do we go from here?Jennifer L Lund, Vincent Lo Re
Current Epidemiology Reports|January 23, 2019
The importance and implications of comparator selection in pharmacoepidemiologic researchMonica D'Arcy, Til Stürmer, Jennifer L Lund
JAMA Internal Medicine|April 4, 2018
Lower Cancer Incidence-Warfarin Effect or Immortal Time Bias?Xiaojuan Li, Jennifer L Lund, Sengwee Toh
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2025
Investigating Racial and Ethnic Disparities Along the Care Cascade for Older Adults Newly Diagnosed With Metastatic CancerJennifer L Lund, Vanessa E Slater, Allison Magnuson
JAMA|September 20, 2012
Benefits and risks of aspirin useJennifer L Lund, Til Stürmer, Henrik Toft-Sørensen
Current Epidemiology Reports|March 9, 2016
The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary applicationJennifer L Lund, David B Richardson, Til Stürmer
Journal of Geriatric Oncology|March 2, 2016
Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapyJennifer L Lund, Til Sturmer, Hanna K Sanoff
Pageof 24